Key result
Prednisolone reverses post-transplant severe myocarditis presenting with cardiogenic shock and advanced AV block.
Why the study?
Myocarditis after allogeneic stem cell transplantation is a rare but potentially fatal complication that requires awareness for timely diagnosis and treatment.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
May warrant steroid consideration in rare post-transplant myocarditis; hypothesis-generating and requires prospective validation.
A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests revealed increased myocardium enzymes, and ultrasonic cardiography demonstrated mild thickening of the left ventricular wall. She was diagnosed with myocarditis and successfully treated using prednisolone. Myocarditis after allogeneic stem cell transplantation is a rare but potentially fatal complication. However, it is important for physicians to be aware of this complication because all of the symptoms may be reversed with immunosuppressive treatment.
No takes yet. Share an insight, caveat, or question.
Sumi et al. (2019) conducted a case report in Myocarditis with advanced atrioventricular block (n=1). Prednisolone was evaluated on Clinical recovery from myocarditis and cardiogenic shock. Prednisolone successfully reversed severe myocarditis presenting as advanced atrioventricular block and cardiogenic shock following allogeneic stem cell transplantation.
Synapse has enriched 10 related papers. Consider them for comparative context: